Johnson KA, Martin N, Nappi RE, Neal-Perry G, et al. Efficacy and Safety of Fezolinetant in Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT. J Clin Endocrinol Metab 2023 Feb 3:dgad058. doi: 10.1210.
PMID: 36734148